NEW YORK (GenomeWeb News) – UK-based point of care diagnostics firm EKF Diagnostics Holdings today announced it has formed a new firm to focus on molecular and companion diagnostics.

To support the creation of the new subsidiary called EKF Molecular Diagnostics, EKF also said that it has acquired cancer diagnostics company 360 Genomics for up to £9.6 million ($14.5 million).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.